Q) Not true about Cross Trial? (Trials in Surgery)
a) Pathological response rate is more in SCC than Adeno CA
b) No change in overall survival
c) Grade III/IV hematological toxicity is less than 10%
d) No difference in overall morbidity and mortality between the two arms
This answer is available only for Premium Members.
Join Premium Surgery Course